K004017

Substantially Equivalent

H-SCRIBE

Applicant: Mortara Instrument, Inc.
Product code: MLO
Advisory panel: Cardiovascular
Date received: 2000-12-27
Decision date: 2001-06-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Milwaukee, WI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.